# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-091650
Filing Date
2025-09-19
Accepted
2025-09-19 16:10:42
Documents
24
Period of Report
2025-11-04

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | pahc-20251104xdef14a.htm iXBRL | DEF 14A | 1453546
2 | GRAPHIC | pahc-20251104xdef14a_a003.jpg | GRAPHIC | 13940
3 | GRAPHIC | pahc-20251104xdef14a_a004.jpg | GRAPHIC | 5131
4 | GRAPHIC | pahc-20251104xdef14a_a017.jpg | GRAPHIC | 62494
5 | GRAPHIC | pahc-20251104xdef14a_a018.jpg | GRAPHIC | 59834
6 | GRAPHIC | pahc-20251104xdef14a_a019.jpg | GRAPHIC | 60617
7 | GRAPHIC | pahc-20251104xdef14a_a020.jpg | GRAPHIC | 48511
8 | GRAPHIC | pahc-20251104xdef14a_bg001.jpg | GRAPHIC | 169980
9 | GRAPHIC | pahc-20251104xdef14a_cg001.jpg | GRAPHIC | 101379
| Complete submission text file | 0001104659-25-091650.txt |  | 4060261

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | EX-101.SCH | pahc-20251104.xsd | EX-101.SCH | 7313
11 | EX-101.DEF | pahc-20251104_def.xml | EX-101.DEF | 54245
12 | EX-101.LAB | pahc-20251104_lab.xml | EX-101.LAB | 5380
13 | EX-101.PRE | pahc-20251104_pre.xml | EX-101.PRE | 5721
26 | EXTRACTED XBRL INSTANCE DOCUMENT | pahc-20251104xdef14a_htm.xml | XML | 450973

Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36410 | Film No.: 251326945
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)